Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide

Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide.

Savvidou S, Karatzidou K, Tsakiri K, Gagalis A, Hytiroglou P, Goulis J.

Diabetes Res Clin Pract. 2016 Mar;113:125-34. doi: 10.1016/j.diabres.2015.12.003. Epub 2016 Jan 9

Για να δείτε το άρθρο πιέστε εδώ